Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ernexa Therapeutics Inc. Director's Dealing 2021

Feb 22, 2021

35259_dirs_2021-02-22_85f8711d-5733-4798-ab2b-be56d6e990e2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2021-02-19

Reporting Person: Gurrola Sandra M (SVP of Finance)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-19 Common Stock F 115 $4.81 Disposed 27827 Direct

Footnotes

F1: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction.